Sickle cell anaemia is an inherited blood disorder characterized by the presence of an abnormal form of hemoglobin, known as hemoglobin S (HbS). Healthy red blood cells are disc-shaped and flexible, allowing them to flow easily through narrow blood vessels. When an individual inherits two mutated genes for hemoglobin—one from each parent—their red blood cells undergo a structural change under low oxygen conditions, adopting a rigid, crescent or sickle shape.
The condition follows an autosomal recessive inheritance pattern. When both parents carry the sickle cell trait (HbAS), each pregnancy carries a 25 percent chance of producing a child with sickle cell anaemia (HbSS), a 50 percent chance of producing a trait carrier, and a 25 percent chance of producing a child with normal hemoglobin (HbAA). Pre-marital genotype counselling remains a vital public health strategy in Nigeria to reduce the incidence of affected births.
The fundamental defect in sickle cell anaemia stems from a single amino acid substitution in the beta-globin chain of the hemoglobin molecule, where valine replaces glutamic acid. Under conditions of hypoxia, dehydration, or acidosis, these mutant hemoglobin molecules stick together and form long polymer chains.
These polymers distort the cell membrane, causing the characteristic sickling. Sickled cells lose their flexibility and cause two major pathological problems:
Clinical features of sickle cell anaemia vary widely depending on the age of the patient and organ system involvement. Infants typically remain asymptomatic for the first few months of life because high levels of fetal hemoglobin offer protection.
Common clinical findings include:
Early detection is critical for reducing childhood mortality from sickle cell anaemia in resource-limited settings like Nigeria. Primary health care centers utilize simple, cost-effective screening tools before definitive laboratory confirmation.
| Test Method | Purpose | Clinical Utility |
|---|---|---|
| Sodium Metabisulfite Test | Screening | Induces sickling in vitro for rapid visual assessment |
| Haemoglobin Electrophoresis | Confirmatory | Separates hemoglobin variants based on electrical charge |
| Isoelectric Focusing | Neonatal | Accurately identifies HbS in newborns from cord blood |
Routine immunization visits provide an ideal opportunity for nurses to advocate for genotype screening and educate nursing mothers.
Acute crises are sudden, severe episodes that require immediate medical intervention to prevent permanent organ damage or death.
Managing pain during a sickle cell crisis requires a systematic, empathetic, and evidence-based nursing approach. Because pain is subjective, nurses must validate the patient's report rather than suspecting drug-seeking behavior.
Initial nursing interventions focus on restoring tissue oxygenation and reversing the factors that triggered sickling. Nurses administer prescribed oxygen therapy, ensure prompt intravenous hydration to decrease blood viscosity, and maintain thermal comfort without using cold compresses. Analgesia follows the World Health Organization pain ladder, utilizing non-opioids for mild pain and scheduled opioids for severe vaso-occlusive pain. Monitoring vital signs, tracking fluid input and output, and watching out for respiratory depression during opioid administration are vital nursing responsibilities.
Nurses play a central role in community mobilization and genetic counseling to curb the burden of sickle cell anaemia. Counseling sessions must be confidential, non-directive, and culturally sensitive, empowering couples to make informed reproductive choices before marriage or conception.
Education for affected families centers on infection prevention, proper nutrition, and recognizing early warning signs of complications. Key health maintenance practices include adherence to routine childhood immunizations, daily malaria chemoprophylaxis with proguanil or penicillin prophylaxis in early childhood, and avoiding extreme temperatures, tight clothing, and strenuous physical exhaustion.
Addressing sickle cell anaemia requires robust public health policies and structural health system improvements across Nigeria. National strategies focus on integrating screening into primary healthcare, reducing maternal and child mortality, and destigmatizing the condition.
Public health policies promote mandatory pre-marital counseling legislation in various states, community awareness campaigns, and subsidized access to hydroxyurea and pneumococcal vaccines. Empowering local healthcare workers with adequate training ensures that individuals living with sickle cell anaemia receive comprehensive, stigma-free care throughout their lives.